Cargando…

Challenges to Licensure of Enterovirus 71 Vaccines

Human enteroviruses usually cause self-limited infections except polioviruses and enterovirus 71 (EV71), which frequently involve neurological complications. EV71 vaccines are being evaluated in humans. However, several challenges to licensure of EV71 vaccines need to be addressed. Firstly, EV71 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Min-Shi, Tseng, Fan-Chen, Wang, Jen-Ren, Chi, Chia-Yu, Chong, Pele, Su, Ih-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429393/ https://www.ncbi.nlm.nih.gov/pubmed/22953003 http://dx.doi.org/10.1371/journal.pntd.0001737

Ejemplares similares

Production of EV71 vaccine candidates
por: Chong, Pele, et al.
Publicado: (2012)

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Mutations in the non-structural protein region contribute to intra-genotypic evolution of enterovirus 71
por: Huang, Sheng-Wen, et al.
Publicado: (2014)

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
por: Mao, Qunying, et al.
Publicado: (2016)

Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71
por: Liao, Yu-Ting, et al.
Publicado: (2015)

A Single Nucleotide in Stem Loop II of 5′-Untranslated Region Contributes to Virulence of Enterovirus 71 in Mice
por: Yeh, Ming-Te, et al.
Publicado: (2011)

CD4 T-Cell-Independent Antibody Response Reduces Enterovirus 71 Lethality in Mice by Decreasing Tissue Viral Loads
por: Wang, Li-Chiu, et al.
Publicado: (2012)

Genetic and Antigenic Characterization of Enterovirus 71 in Ho Chi Minh City, Vietnam, 2011
por: Thoa, Le Phan Kim, et al.
Publicado: (2013)

112 The Development of Enterovirus 71 Vaccine
por: Xiuling, Li, et al.
Publicado: (2014)

Recombinant Adeno-Vaccine Expressing Enterovirus 71-Like Particles against Hand, Foot, and Mouth Disease
por: Tsou, Yueh-Liang, et al.
Publicado: (2015)

Enterovirus 71 infection and vaccines
por: Yi, Eun-Je, et al.
Publicado: (2017)

Enterovirus A71 Vaccines
por: Li, Mei-Ling, et al.
Publicado: (2021)

Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Monitoring Antigenic Variations of Enterovirus 71: Implications for Virus Surveillance and Vaccine Development
por: Chia, Min-Yuan, et al.
Publicado: (2014)

The Association between Enterovirus 71 Infections and Meteorological Parameters in Taiwan
por: Chang, Hsiao-Ling, et al.
Publicado: (2012)

Enterovirus A71: virulence, antigenicity, and genetic evolution over the years
por: Huang, Sheng-Wen, et al.
Publicado: (2019)

Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71
por: Lin, Yi-Wen, et al.
Publicado: (2013)

Reemergence of Enterovirus 71 Epidemic in Northern Taiwan, 2012
por: Luo, Shu-Ting, et al.
Publicado: (2015)

Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice
por: Huang, Szu-Wei, et al.
Publicado: (2011)

Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations
por: Linsuwanon, Piyada, et al.
Publicado: (2014)

Timing of Endotracheal Intubation in Patients with Fulminant Enterovirus 71 Infection
por: Chen, Shen-Dar, et al.
Publicado: (2020)

Development of Novel Vaccines against Enterovirus-71
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2015)

Enterovirus 71 vaccine: close but still far
por: Zhang, Dingmei, et al.
Publicado: (2010)

Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells
por: Su, Pei-Yi, et al.
Publicado: (2012)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Receptors for enterovirus 71
por: Yamayoshi, Seiya, et al.
Publicado: (2014)

Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
por: Eyal, Nir, et al.
Publicado: (2020)

Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers
por: Chou, Ai-Hsiang, et al.
Publicado: (2013)

Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model
por: Lee, Ying-Ray, et al.
Publicado: (2014)

Novel Naturally Occurring Mutations of Enterovirus 71 Associated With Disease Severity
por: Chang, Chih-Shin, et al.
Publicado: (2021)

Enterovirus 71 Maternal Antibodies in Infants, Taiwan
por: Luo, Shu-Ting, et al.
Publicado: (2009)

Inactivated enterovirus A71 vaccines and moving forward
por: Shimizu, Hiroyuki
Publicado: (2021)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model
por: Lei, Li, et al.
Publicado: (2021)

Cross-reactive Neutralizing Antibody Responses to Enterovirus 71 Infections in Young Children: Implications for Vaccine Development
por: Huang, Mei-Liang, et al.
Publicado: (2013)

Enterovirus 71 infection and neurological complications
por: Lee, Kyung Yeon
Publicado: (2016)

Enterovirus 71 Outbreak, Brunei
por: AbuBakar, Sazaly, et al.
Publicado: (2009)

Recombinant Human Enterovirus 71
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_uml2jtop3b7jn204v7jc9kt0hc